Kahn Brothers Group Inc's NVS Position
Novartis AG Sponsored ADR — 10 quarters (Q4 2023 to Q4 2025)
Current Shares
13.7K
Current Value
$1.89M
Peak Shares
21.9K
Q1 2025
Overall Change
-24%
Shares Over Time
Q4 2023
18.1K
Q1 2024
15.4K
-15%
Q2 2024
17.6K
+14%
Q3 2024
17.6K
0%
Q4 2024
21.2K
+20%
Q1 2025
21.9K
+3%
Q2 2025
18.5K
-16%
Q3 2025
14.3K
-22%
Q3 2025
14.3K
0%
Q4 2025
13.7K
-5%
Quarterly Detail
| Quarter | Shares | Value | $/Share | Change |
|---|---|---|---|---|
| Q4 2025 | 13.7K | $1.89M | $137.89 | -5% |
| Q3 2025 | 14.3K | $1.84M | $128.23 | 0% |
| Q3 2025 | 14.3K | $1.84M | $128.23 | -22% |
| Q2 2025 | 18.5K | $2.24B | $121009.96 | -16% |
| Q1 2025 | 21.9K | $2.44M | $111.51 | +3% |
| Q4 2024 | 21.2K | $2.06B | $97293.42 | +20% |
| Q3 2024 | 17.6K | $2.02B | $115011.89 | 0% |
| Q2 2024 | 17.6K | $1.87B | $106464.48 | +14% |
| Q1 2024 | 15.4K | $1.49B | $96741.45 | -15% |
| Q4 2023 | 18.1K | $1.82B | $100988.98 | New |